UBS Group
CDIOW icon

UBS Group’s Cardio Diagnostics Holdings Inc Warrant CDIOW Stock Holding History

UBS Group’s Portfolio CDIOW Stock Details CDIOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$67 Hold
5,561
– – ﹤0.01% 10160
2026
Q1 		$89 Buy
5,561
+1,639
+42% +$37 ﹤0.01% 10135
2025
Q4 		$102 Buy
3,922
+3,771
+2,497% +$80 ﹤0.01% 10182
2025
Q3 		$3 Sell
151
-774
-84% -$13 ﹤0.01% 10248
2025
Q2 		$15 Sell
925
-226
-20% -$5 ﹤0.01% 10135
2025
Q1 		$46 Buy
+1,151
New +$70 ﹤0.01% 10022
2024
Q4 		– Sell
-9,737
Closed -$380 – 9962
2024
Q3 		$380 Sell
9,737
-264
-3% -$10 ﹤0.01% 8966
2024
Q2 		$390 Buy
10,001
+4,875
+95% +$296 ﹤0.01% 8943
2024
Q1 		$543 Buy
5,126
+4,208
+458% +$631 ﹤0.01% 8489
2023
Q4 		$160 Buy
918
+771
+524% +$77 ﹤0.01% 8856
2023
Q3 		$5 Buy
+147
New +$16 ﹤0.01% 9272
2023
Q2 		– Sell
-622
Closed -$199 – 8980
2023
Q1 		$199 Buy
622
+570
+1,096% +$134 ﹤0.01% 9140
2022
Q4 		$3 Buy
52
+40
+333% +$5 ﹤0.01% 10635
2022
Q3 		$0 Sell
12
-88
-88% -$12 ﹤0.01% 10377
2022
Q2 		$0 Buy
+100
New +$19 ﹤0.01% 10359

Other funds holding CDIOW

BFM
Boothbay Fund Management New York $7.6B AUM 109.3% 1-Year Est. Return
SCM
Saba Capital Management New York $3.9B AUM 12.9% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return

UBS Group's CDIOW Position: Q2 2026 in Review

UBS Group held its Cardio Diagnostics Holdings Inc Warrant (CDIOW) position steady in Q2 2026 at 5,561 shares worth $67. The position accounts for ﹤0.01% of the portfolio, ranked #10160.

UBS Group first reported a position in CDIOW in Q2 2022 and has held it in 15 quarters since. The position peaked at $543 in Q1 2024. 7 funds tracked by Wall St. Rank hold CDIOW as of Q2 2026.

  • UBS Group held 5,561 shares of Cardio Diagnostics Holdings Inc Warrant worth $67 as of Q2 2026.
  • UBS Group left its Cardio Diagnostics Holdings Inc Warrant share count unchanged in Q2 2026.
  • Cardio Diagnostics Holdings Inc Warrant made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #10160 holding.
  • UBS Group first reported a position in Cardio Diagnostics Holdings Inc Warrant in Q2 2022 and has held it in 15 quarters since.
  • UBS Group's Cardio Diagnostics Holdings Inc Warrant position peaked at $543 in Q1 2024.
  • 7 funds tracked by Wall St. Rank held Cardio Diagnostics Holdings Inc Warrant as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.